Table 3.
Degree of anterior knee pain, by knee activity.
| Activity | 3-month follow up n (%) | 6-month follow up n (%) | p-value |
|---|---|---|---|
| Ascending 30° slope | |||
| - no pain | 17 (48.6%) | 29 (82.9%) | |
| - mild | 17 (48.6%) | 6 (17.1%) | |
| - moderate | 1 (2.9%) | 0 (0%) | |
| - severe pain | 0 (0%) | 0 (0%) | 0.990 |
| Running | |||
| - no pain | 16 (45.7%) | 25 (71.4%) | |
| - mild | 19 (54.3%) | 10 (28.6%) | |
| - moderate | 0 (0%) | 0 (0%) | |
| - severe pain | 0 (0%) | 0 (0%) | 0.999 |
| Ascending stairs | |||
| - no pain | 12 (34.3%) | 19 (54.3%) | |
| - mild | 19 (54.3%) | 15 (42.9%) | |
| - moderate | 4 (11.4%) | 1 (2.9%) | |
| - severe pain | 0 (0%) | 0 (0%) | 0.375 |
| Descending stairs | |||
| - no pain | 11 (31.4%) | 23 (65.7%) | |
| - mild | 19 (54.3%) | 11 (31.4%) | |
| - moderate | 5 (14.3%) | 1 (2.9%) | |
| - severe pain | 0 (0%) | 0 (0%) | 0.219 |
| Sitting cross-legged | |||
| - no pain | 26 (74.3%) | 34 (97.1%) | |
| - mild | 9 (25.7%) | 1 (2.9%) | |
| - moderate | 0 (0%) | 0 (0%) | |
| - severe pain | 0 (0%) | 0 (0%) | 0.999 |
| Sitting one-legged | |||
| - no pain | 28 (80.0%) | 32 (91.4%) | |
| - mild | 6 (17.1%) | 2 (5.7%) | |
| - moderate | 1 (2.9%) | 1 (2.9%) | |
| - severe pain | 0 (0%) | 0 (0%) | 0.999 |
| Jumping | |||
| - no pain | 4 (11.4%) | 14 (40.0%) | |
| - mild | 23 (65.7%) | 19 (54.3%) | |
| - moderate | 8 (22.9%) | 2 (5.7%) | |
| - severe pain | 0 (0%) | 0 (0%) | 0.070a |
| Squatting | |||
| - no pain | 16 (45.7%) | 22 (62.9%) | |
| - mild | 13 (37.1%) | 13 (37.1%) | |
| - moderate | 6 (17.1%) | 0 (0%) | |
| - severe pain | 0 (0%) | 0 (0%) | 0.031a |
| Kneeling | |||
| - no pain | 3 (9.1%) | 10 (29.4%) | |
| - mild | 13 (39.4%) | 15 (44.1%) | |
| - moderate | 12 (36.4%) | 7 (20.6%) | |
| - severe pain | 5 (15.2%) | 2 (5.9%) | 0.039a |
Degree of anterior knee pain determined by VAS for pain: VAS = 0, no pain; VAS = 1–3, mild pain; VAS = 4–7, moderate pain; and VAS = 8–10, severe pain.
Difference of the considerable knee pain as a VAS pain score ≥4 of each activity with level of significant (p-value less than 0.05).